June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$247.21 |
Change
-3.450(1.38%) |
Mkt cap ! $119.6B | |||
| Open | High | Low | Value | Volume |
| $250.60 | $251.00 | $245.46 | $105.4M | 427.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 50 | $247.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $247.23 | 59 | 8 |
View Market Depth
| Last trade - 15.50pm 16/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |